Literature DB >> 22546061

Metabolic monitoring training program implementation in the community setting was associated with improved monitoring in second-generation antipsychotic-treated children.

Rebecca Ronsley1, Mark Rayter, Derryck Smith, Jana Davidson, Constadina Panagiotopoulos.   

Abstract

OBJECTIVE: To determine whether implementation of a metabolic monitoring training program (MMTP) in an urban community-based setting improved monitoring in children treated with second-generation antipsychotics (SGAs) and changed prescription rates of SGAs to children.
METHOD: The MMTP was implemented in the Vancouver Coastal Health Child and Youth Mental Health Teams (CYMHTs) on January 1, 2009. A retrospective review of paper charts and electronic records for children seen at the CYMHTs from September 1, 2007, to May 1, 2010, was performed to collect the following data: age, sex, foster care, immigrant status, Axis I diagnosis, and medications. In SGA-treated children, anthropometric measurements and blood work completed at baseline and 3, 6, and 12 months were also collected.
RESULTS: Among the 1114 children seen pre-MMTP and 1262 children seen post-MMTP implementation, 174 (15.4%) and 81 (6.4%), respectively, were SGA-treated (P < 0.001). Among the SGA-treated children seen at the CYMHTs after MMTP implementation, 38.3% had a copy of the MMTP in their paper chart. Metabolic monitoring increased by up to 40% at baseline (P < 0.01), 20% at 3 (P < 0.01) and 6 months (P < 0.01), and 18% at 12 months after MMTP implementation.
CONCLUSIONS: Implementation of an MMTP was associated with significantly improved monitoring rates of anthropometric and blood work parameters at baseline and the 3- and 6-month time points, with a trend for improvement at the 12-month time point, in SGA-treated children cared for in urban community mental health clinics. In addition, a 56% decrease in SGA prescriptions was observed following MMTP implementation in this population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22546061     DOI: 10.1177/070674371205700504

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  10 in total

1.  Antipsychotic Cardiometabolic Side Effect Monitoring in a State Community Mental Health System.

Authors:  Robert O Cotes; Alex de Nesnera; Michael Kelly; Karen Orsini; Haiyi Xie; Greg McHugo; Stephen Bartels; Mary F Brunette
Journal:  Community Ment Health J       Date:  2015-02-03

2. 

Authors:  Clare Lambert; Constadina Panagiotopoulos; Jana Davidson; Ran D Goldman
Journal:  Can Fam Physician       Date:  2018-09       Impact factor: 3.275

3.  Improving Cardiometabolic Monitoring of Children on Antipsychotics.

Authors:  Robert O Cotes; Nisha K Fernandes; Jennifer L McLaren; Gregory J McHugo; Stephen J Bartels; Mary F Brunette
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-06-05       Impact factor: 2.576

4.  Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada.

Authors:  Wenxin Chen; Monica Cepoiu-Martin; Antonia Stang; Diane Duncan; Chris Symonds; Lara Cooke; Tamara Pringsheim
Journal:  Clin Drug Investig       Date:  2018-05       Impact factor: 2.859

5.  Second-generation antipsychotics in children: Risks and monitoring needs.

Authors:  Clare Lambert; Constadina Panagiotopoulos; Jana Davidson; Ran D Goldman
Journal:  Can Fam Physician       Date:  2018-09       Impact factor: 3.275

6.  Systematic Quality Improvement and Metabolic Monitoring for Individuals Taking Antipsychotic Drugs.

Authors:  Takahiro Soda; Jennifer Richards; Bradley N Gaynes; Michelle Cueva; Jeffrey Laux; Christine McClain; Rachel Frische; Lisa K Lindquist; Gary S Cuddeback; L Fredrik Jarskog
Journal:  Psychiatr Serv       Date:  2021-04-23       Impact factor: 4.157

7.  SENTIA: a systematic online monitoring registry for children and adolescents treated with antipsychotics.

Authors:  Inmaculada Palanca-Maresca; Belén Ruiz-Antorán; Gustavo Centeno-Soto; Sara Jiménez-Fernandez; Lourdes García-Murillo; Ana Siles; Sandra Villagrá; Hilario Blasco-Fontecilla; Luis Iruela-Cuadrado; Enriqueta Roman-Riechman; Cristina Avendaño-Solá; Christoph U Correll
Journal:  Springerplus       Date:  2014-04-14

Review 8.  Quality improvement, implementation, and dissemination strategies to improve mental health care for children and adolescents: a systematic review.

Authors:  Valerie L Forman-Hoffman; Jennifer Cook Middleton; Joni L McKeeman; Leyla F Stambaugh; Robert B Christian; Bradley N Gaynes; Heather Lynne Kane; Leila C Kahwati; Kathleen N Lohr; Meera Viswanathan
Journal:  Implement Sci       Date:  2017-07-24       Impact factor: 7.327

9.  Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents: A Patient Record Review.

Authors:  Mariken Dinnissen; Andrea Dietrich; Judith H van der Molen; Anne M Verhallen; Ynske Buiteveld; Suzanne Jongejan; Pieter W Troost; Jan K Buitelaar; Barbara J van den Hoofdakker; Pieter J Hoekstra
Journal:  J Clin Psychopharmacol       Date:  2021 Jan/Feb 01       Impact factor: 3.118

10.  Long-Term Metabolic Monitoring of Youths Treated with Second-Generation Antipsychotics 5 Years after Publication of the CAMESA Guidelines Are We Making Progress? Surveillance Métabolique à Long Terme des Jeunes Traités par Antipsychotiques de Deuxième Génération, Cinq ans Après la publication des Lignes Directrices Camesa: Faisons-Nous des Progrès?

Authors:  Sarra Jazi; Leila Ben-Amor; Pascale Abadie; Marie-Line Menard; Rachel Choquette; Claude Berthiaume; Laurent Mottron; Drigissa Ilies
Journal:  Can J Psychiatry       Date:  2020-11-26       Impact factor: 4.356

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.